Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
MREO | Mereo BioPharma Group plc | Chief Patient Access and Commercial Planning | $213K | -$1.05M | -83.1% | Sep 12, 2024 |
Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
---|